RS Pondok Indah Group becomes
Indonesia’s first healthcare provider to achieve HIMSS Stage 7 EMRAM, advancing
digital healthcare excellence.
Indonesia: RS
Pondok Indah Group has become the first healthcare organisation in Indonesia to
achieve Stage 7 validation under the HIMSS Electronic Medical Record Adoption
Model (EMRAM). The milestone covers its three hospitals – RS Pondok Indah -
Pondok Indah, RS Pondok Indah - Puri Indah, and RS Pondok Indah - Bintaro Jaya
– making them the most digitally advanced hospitals in the country.
The group’s journey from Stage 6,
validated in 2022, required implementing a drug batch number tracking system to
enhance adverse event reporting. “This project required a thorough analysis
as it involved significant changes to workflows across multiple departments,
including physicians, warehouse staff, pharmacy, and nursing,” said CEO Dr
Yanwar Hadiyanto.
A key highlight of the validation was
the digital patient journey initiative, which reduced no-show rates, improved waiting
times, and cut annual call centre costs by IDR 280 million (USD 17,000). “To
facilitate this transition, we focused on minimising physical document
exchanges, speeding up service processes, reducing no-show rates, enhancing
data accuracy, lowering operational costs, and promoting environmentally
friendly practices,” noted chief IT officer Imam Daru Nurwijayanto.
HIMSS validators praised innovations
such as the “one QR code” outpatient system, bedside Smart Medical Broadcaster,
structured clinical documentation, and integrated ICU devices. These
advancements enhanced patient safety, data accuracy, and workflow efficiency.
“Achieving HIMSS EMRAM Stage 7 is a
significant milestone for our organisation, reflecting our commitment to
digital healthcare. We effectively maximised EMR usage, supported by strong
data governance, clinical decision support systems, data mobilisation, and
interoperability, which led to improved workflow efficiency, enhanced team
collaboration, empowered clinicians, and better patient outcomes and engagement,” Dr Hadiyanto added. The group
now aims to progress further with an assessment under the HIMSS Digital Health
Indicator.
According to TechSci
Research, RS
Pondok Indah Group’s achievement of HIMSS Stage 7 EMRAM is significant for the
global healthcare industry as it showcases how advanced EMR adoption directly
improves patient safety, operational efficiency, and care quality. By
implementing systems such as drug batch number tracking, integrated ICU device
monitoring, structured clinical documentation, and digital patient journey
management, the group demonstrated measurable outcomes including reduced
appointment no-show rates, shorter wait times, improved data accuracy, and
lower operational costs. These results highlight the tangible benefits of
digital transformation in healthcare, offering a clear example for other
hospitals worldwide to follow. Validation also reinforces the importance of
interoperability, clinical decision support, and strong data governance in
modern healthcare systems. Such advancements collectively support more reliable
patient care, improved workflow collaboration among clinical teams, and better resource
utilization, ultimately contributing to higher standards of healthcare delivery
across the industry.